Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

Masterrunner Aug. 11 at 12:34 AM

$SBFM Perma-bulls saw “$5.2B market” and forget SBFM’s favorite product is its own stock. 😂 12M units + 24M warrants after ~5M shares outstanding. Dienogest is already genericized with multiple competitors. No sales. No market share. The last PR is just a giant hollow headline with glossy numbers. Show me revenue growing faster than dilution. Until then, enjoy the PR pump & dump. 💀

1 · Reply

hotslots Aug. 10 at 7:34 PM

$SBFM pos hasnt budged allday. Must be inking the deal now for 35 milly

1 · Reply

uddin Aug. 10 at 2:04 PM

$SBFM uptrend

0 · Reply

uddin Aug. 10 at 1:11 PM

$SBFM Buying opportunity

0 · Reply

KingsPlay92 Aug. 10 at 11:21 AM

$SBFM next stop OTC markets

1 · Reply

Hankies Aug. 10 at 11:11 AM

$SBFM So, no shares available to short on IBKR. Is this going to pop or drop below a dollar yet again? Hopefully the former but likely the latter.

0 · Reply

spaarrow1 Aug. 10 at 8:38 AM

$SBFM We are not waiting for news. Now We wait 3-6 monthis for Revenue figures.

2 · Reply

hotslots Aug. 10 at 2:01 AM

$SBFM news leak??

1 · Reply

contra7 Aug. 8 at 1:45 PM

$SBFM Extremely

1 · Reply

Masterrunner Aug. 8 at 1:40 PM

$SBFM

0 · Reply

Sunshine Biopharma launches generic amoxicillin formulation in Canada

Aug 7, 2026, 9:00 AM EDT - 3 days ago

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market

2026-08-04T13:16:02.000Z - 6 days ago

Sunshine announces approval of generic Dienogest tablets for Canadian market

Aug 4, 2026, 9:00 AM EDT - 6 days ago

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

2026-07-28T12:21:42.000Z - 13 days ago

Sunshine Biopharma announces approval of generic Ondansetron tablets

Jul 28, 2026, 8:00 AM EDT - 13 days ago

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting

2026-07-20T12:45:19.000Z - 21 days ago

Sunshine Biopharma announces publication of new results on MR1-114

Jul 20, 2026, 8:30 AM EDT - 21 days ago

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings

2026-06-25T12:20:47.000Z - 6 weeks ago

Sunshine Biopharma receives Canadian approval for generic Arimidex

Jun 25, 2026, 8:00 AM EDT - 6 weeks ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

2026-06-01T12:23:56.000Z - 2 months ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

2026-05-29T23:55:22.000Z - 2 months ago

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T13:11:09.000Z - 2 months ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

May 29, 2026, 8:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

2026-05-28T14:49:55.000Z - 2 months ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

May 28, 2026, 9:00 AM EDT - 2 months ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

2026-05-21T11:17:11.000Z - 2 months ago

Sunshine announces approval of generic amoxicillin formulation for Canada

May 21, 2026, 7:00 AM EDT - 2 months ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

2026-05-19T16:21:43.000Z - 2 months ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

May 19, 2026, 12:05 PM EDT - 2 months ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 3 months ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

2026-05-18T12:55:34.000Z - 3 months ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-12T21:20:04.000Z - 3 months ago

Sunshine Biopharma files to sell 5.825M common units

2026-04-06T12:53:12.000Z - 4 months ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:52:43.000Z - 4 months ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Apr 6, 2026, 8:30 AM EDT - 4 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 10 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

2025-10-28T11:50:45.000Z - 10 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Oct 28, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

2025-10-20T11:50:37.000Z - 10 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Oct 20, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025, 7:45 AM EDT - 10 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 10 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 10 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 7:00 AM EDT - 10 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025, 8:00 AM EDT - 10 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 3 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

Masterrunner Aug. 11 at 12:34 AM

1 · Reply

hotslots Aug. 10 at 7:34 PM

$SBFM pos hasnt budged allday. Must be inking the deal now for 35 milly

1 · Reply

uddin Aug. 10 at 2:04 PM

$SBFM uptrend

0 · Reply

uddin Aug. 10 at 1:11 PM

$SBFM Buying opportunity

0 · Reply

KingsPlay92 Aug. 10 at 11:21 AM

$SBFM next stop OTC markets

1 · Reply

Hankies Aug. 10 at 11:11 AM

$SBFM So, no shares available to short on IBKR. Is this going to pop or drop below a dollar yet again? Hopefully the former but likely the latter.

0 · Reply

spaarrow1 Aug. 10 at 8:38 AM

$SBFM We are not waiting for news. Now We wait 3-6 monthis for Revenue figures.

2 · Reply

hotslots Aug. 10 at 2:01 AM

$SBFM news leak??

1 · Reply

contra7 Aug. 8 at 1:45 PM

$SBFM Extremely

1 · Reply

Masterrunner Aug. 8 at 1:40 PM

$SBFM

0 · Reply

spaarrow1 Aug. 8 at 6:50 AM

$SBFM any1 with a brain can see that their new Drug which is a pill. That can be mass produced and sold will in a pharma for a recipe from doctor Will sell for hundreds of million. I lock my shares in my vault and gonna buy 500 shares every month. Use ur head. This is a 200 usd stock. Probably BO in 2 years for 1. 5 billion.

2 · Reply

dario2580 Aug. 8 at 12:50 AM

$SBFM 2025 revenue +4.1% → $36.3M

1 · Reply

hotslots Aug. 7 at 9:43 PM

$SBFM bankruptcy

1 · Reply

KeailiIlani4U Aug. 7 at 8:43 PM

$SBFM Do you guys know if this Company sells Band-Aids? Going to need some because I lost 6 cents per share on 6 shares😳😳😳🙄

0 · Reply

Luka_Brasi Aug. 7 at 8:34 PM

$SBFM T$SBFM These guys cured cancer for Christ sake That's the most valuable discovery in history.

1 · Reply

MB66 Aug. 7 at 8:26 PM

$SBFM this looks like good old dilute rinse repeat in action. Only this management can take a few positive PR’s and drive the share price near all-time lows!! It’s their signature move!!

0 · Reply

FM99 Aug. 7 at 8:02 PM

$SBFM last minute and the tape got crazy… keeping this on watch

0 · Reply

disdaniel Aug. 7 at 7:38 PM

$SBFM why is this suddenly getting sold hard?

0 · Reply

Paxter Aug. 7 at 7:17 PM

$SBFM I once had money and no problems with my wife that was just a couple years ago AND my investment change eveything

3 · Reply

KeailiIlani4U Aug. 7 at 7:13 PM

$SBFM Am the proud owner of 6 shares F.U. Slilaty🤣🤣😃

0 · Reply

Merkel Aug. 7 at 6:59 PM

$SBFM Next Runner CHR Revenue: $120M Cash: $200M Profit: $20M Current Marketcap: $3.5M Share price: $1,86

0 · Reply

Masterrunner Aug. 7 at 6:38 PM

$SBFM Yes, loading zone than comes dumping zone

1 · Reply

Market Cap	616,000.00
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	343,400
Avg Vol	712,761
Day's Range	N/A - N/A
Shares Out	501,000.00
Stochastic %K	29%
Beta	1.16
Analysts	Sell
Price Target	$56.00